# PharmaAgent Pro

## AI-Powered Pharmaceutical Intelligence Platform

---

*Confidential | April 2026*

---

<!-- SLIDE 1: TITLE -->

# PharmaAgent Pro

### Accelerating Drug Development with Agentic AI

**Built on Claude's Managed Agent Platform**

```
    +-------+
    |       |    PharmaAgent Pro
    |   P   |    Pharmaceutical Intelligence
    |       |    Powered by Claude
    +-------+
```

*From compound to clinic -- faster, safer, smarter.*

---

<!-- SLIDE 2: THE PROBLEM -->

## The Problem: Drug Development Is Broken

### $2.6 Billion & 12 Years

That's the average cost and time to bring a single drug to market.

```
  Compound    Preclinical    Phase I    Phase II    Phase III    FDA Review
  Discovery   Testing        Trial      Trial       Trial       & Approval
  |           |              |          |           |            |
  |-- 3-6 yr--|-- 1-2 yr ----|-- 1-3 yr-|-- 2-3 yr--|-- 1-2 yr --|
  |           |              |          |           |            |
  10,000      250            5          ---         1            1
  compounds   enter          enter      -----       enters       APPROVED
  screened    preclinical    clinical   -------     Phase III
```

### What's Going Wrong?

| Challenge | Impact |
|-----------|--------|
| **Data Silos** | Compound data, trial results, and safety signals live in disconnected systems |
| **Manual Document Generation** | Regulatory teams spend 40%+ of time on document formatting, not strategy |
| **Delayed Safety Detection** | Adverse event patterns spotted weeks late due to manual review processes |
| **Knowledge Fragmentation** | Critical drug interaction data scattered across teams and databases |
| **Compliance Burden** | FDA/ICH requirements demand meticulous documentation that's error-prone when manual |

### The Cost of Delay

- Every **month** of delay in drug approval = **$30-100M** in lost revenue
- Late-stage trial failures due to missed safety signals = **$800M-1.5B** wasted
- FDA rejection due to incomplete submissions = **6-12 months** of rework

---

<!-- SLIDE 3: OUR SOLUTION -->

## The Solution: PharmaAgent Pro

### An AI Agent That Thinks Like Your Best Researcher

PharmaAgent Pro is a multi-agent AI system purpose-built for pharmaceutical R&D. It doesn't just answer questions -- it **reasons**, **retrieves data**, **analyzes safety signals**, and **generates compliant documents** autonomously.

```
  +------------------------------------------------------------------+
  |                                                                    |
  |    "Analyze Oncolytin-B safety        +---------------------+     |
  |     and generate a CIOMS report"  --> | PharmaAgent Pro      |     |
  |                                       |                      |     |
  |                                       | 1. Routes to Safety  |     |
  |                                       |    Agent             |     |
  |                                       | 2. Retrieves AE data |     |
  |                                       | 3. Detects ILD signal|     |
  |                                       | 4. Generates CIOMS   |     |
  |                                       | 5. Validates vs ICH  |     |
  |                                       +---------------------+     |
  |                                              |                     |
  |                                              v                     |
  |    Complete safety analysis + CIOMS report in < 60 seconds         |
  |    (Previously: 2-3 days of manual work)                           |
  |                                                                    |
  +------------------------------------------------------------------+
```

### Four Specialized AI Agents, One Platform

| Agent | What It Does | Value |
|-------|-------------|-------|
| **Drug Discovery Agent** | Compound profiling, drug-likeness, CYP interactions, SAR analysis | Reduce early-stage screening time by 10x |
| **Clinical Trials Agent** | Trial status, enrollment tracking, endpoint analysis, interim results | Real-time trial intelligence |
| **Regulatory Agent** | FDA/ICH-compliant document generation (IND, CSR, CIOMS, DSUR) | 80% reduction in document prep time |
| **Safety Agent** | AE analysis, signal detection, benefit-risk assessment | Detect safety signals in seconds, not weeks |

---

<!-- SLIDE 4: HOW IT WORKS -->

## How It Works

### Intelligent Query Routing

```
  User asks a question
         |
         v
  +------------------+
  | AI Classifier     |     Determines the best specialist
  | (< 100ms)        |     agent for the question
  +--------+---------+
           |
     +-----+-----+-----+-----+
     |     |     |     |     |
     v     v     v     v     v
   Drug  Trial  Reg  Safety General
   Agent Agent Agent Agent  Agent
     |     |     |     |     |
     v     v     v     v     v
  Specialized tools + deep reasoning
         |
         v
  Synthesized, compliant response
```

### Key Technology Decisions

| Feature | How It Works | Why It Matters |
|---------|-------------|---------------|
| **Multi-Model AI** | Fast classifier (Haiku) routes to deep reasoner (Opus) | 95% cost savings on routing without sacrificing quality |
| **Extended Thinking** | Claude shows its reasoning chain for complex analyses | Transparent, auditable AI decision-making |
| **Tool-Based Retrieval** | AI decides what data to fetch, fetches it, then synthesizes | Precise, auditable data access (not black-box RAG) |
| **Prompt Caching** | Repeated conversations reuse cached context | 90% cost reduction on follow-up questions |
| **Guardrails** | PII redaction, injection defense, compliance validation | Pharma-grade safety by design |

---

<!-- SLIDE 5: PRODUCT SCREENSHOTS -->

## Product Experience

### Terminal Chat Interface

```
  +---------------------------------------------------------------+
  |  PharmaAgent Pro -- Managed Agent Chatbot                      |
  |  Session: sesn_011Ca2LmvdpSxD6TxzYM6Hoi                       |
  |  Agent: agent_011Ca1Foj3XLLmpz68mZXcea                        |
  |  Type your query or 'quit' to exit.                            |
  +---------------------------------------------------------------+
  |                                                                 |
  |  You > Which compounds target EGFR?                             |
  |                                                                 |
  |  (thinking...)                                                  |
  |  Custom Tool: drug_lookup                                       |
  |                                                                 |
  |  Based on our compound library analysis, **Oncolytin-B**        |
  |  (PHA-002) is the compound that targets EGFR:                   |
  |                                                                 |
  |  - Compound: Oncolytin-B (PHA-002)                              |
  |  - Class: Kinase Inhibitor                                      |
  |  - Target: EGFR/HER2 dual inhibitor                             |
  |  - Phase: Phase III (ONCOLYZE-3 trial)                          |
  |  - IC50: 2.3 nM (EGFR), 8.1 nM (HER2)                         |
  |  - Indication: Non-Small Cell Lung Cancer                       |
  |                                                                 |
  +---------------------------------------------------------------+
```

### Web Chat Interface

```
  +---------------------------------------------------------------+
  | [P] PharmaAgent Pro                              * Connected   |
  |     Pharmaceutical Intelligence                  [New Session] |
  +---------------------------------------------------------------+
  |                                                                 |
  |  +--------------------------------------------------+          |
  |  | YOU                                               |          |
  |  | Run safety signal analysis on Oncolytin-B         |          |
  |  +--------------------------------------------------+          |
  |                                                                 |
  |  +--------------------------------------------------+          |
  |  | PHARMAAGENT PRO                                   |          |
  |  |                                                   |          |
  |  | [safety_signal_analysis]  [adverse_event_search]  |          |
  |  |                                                   |          |
  |  | ## Safety Signal Analysis: Oncolytin-B            |          |
  |  |                                                   |          |
  |  | **Overall Signal Status: ALERT**                  |          |
  |  |                                                   |          |
  |  | | Metric         | Value              |           |          |
  |  | |----------------|--------------------|           |          |
  |  | | Total AEs      | 3                  |           |          |
  |  | | Serious AEs    | 2 (ILD, QTc)       |           |          |
  |  | | Grade 3+       | 2                  |           |          |
  |  | | Signal         | ILD (Respiratory)  |           |          |
  |  |                                                   |          |
  |  | **Recommendation**: Immediate DSMB review         |          |
  |  +--------------------------------------------------+          |
  |                                                                 |
  +---------------------------------------------------------------+
  | [Analyze Nexavirin] [ONCOLYZE-3 Status] [Safety: Oncolytin-B] |
  | [CIOMS Report] [Drug Interactions] [All SAEs]                  |
  +---------------------------------------------------------------+
```

### API Server (FastAPI)

```
  +---------------------------------------------------------------+
  | http://localhost:8000/docs                                      |
  +---------------------------------------------------------------+
  |                                                                 |
  |  PharmaAgent Pro API                                            |
  |                                                                 |
  |  POST /chat        Send a message and get AI response           |
  |  GET  /status      System status, agents, usage stats           |
  |  POST /memory      Write to persistent memory                   |
  |  GET  /usage       Token usage & cost tracking                  |
  |  GET  /audit       Compliance audit trail                       |
  |  GET  /health      Health check                                 |
  |                                                                 |
  +---------------------------------------------------------------+
```

---

<!-- SLIDE 6: BENEFITS & IMPACT -->

## Benefits & Potential Impact

### Quantified Value

```
  BEFORE PharmaAgent Pro              AFTER PharmaAgent Pro
  ----------------------              ---------------------

  Safety Signal Detection             Safety Signal Detection
  [==========] 2-4 weeks              [=] < 60 seconds
                                       >>> 99% faster

  CIOMS Report Generation             CIOMS Report Generation
  [========] 2-3 days                  [=] < 2 minutes
                                       >>> 99% faster

  Compound Interaction Check           Compound Interaction Check
  [=====] 4-6 hours                    [=] < 30 seconds
                                       >>> 99% faster

  IND Annual Report Draft              IND Annual Report Draft
  [===========] 3-5 days               [==] 10-15 minutes
                                       >>> 97% faster
```

### Impact by Stakeholder

| Stakeholder | Benefit | Metric |
|-------------|---------|--------|
| **Medicinal Chemists** | Instant compound profiling, interaction checks, Lipinski assessment | 10x faster lead screening |
| **Clinical Operations** | Real-time trial dashboards, enrollment tracking, interim analysis | Eliminate weekly report cycles |
| **Regulatory Affairs** | Auto-generated compliant documents with validation | 80% reduction in prep time |
| **Pharmacovigilance** | Automated signal detection, SAE triage, benefit-risk assessment | Same-day signal detection |
| **Medical Writing** | Structured document scaffolds with compliance metadata | Focus on content, not formatting |
| **Executive Leadership** | Cross-portfolio visibility, cost-per-query tracking | Data-driven pipeline decisions |

### Safety & Compliance by Design

```
  +------------------------------------------------------------+
  |                     GUARDRAIL PIPELINE                      |
  |                                                              |
  |   INPUT                                         OUTPUT       |
  |    |                                              ^          |
  |    v                                              |          |
  |  [PII Detection]                           [PII Redaction]  |
  |  [Injection Defense]                   [Medical Advice Warn] |
  |  [Prohibited Topics]                   [Compliance Footer]  |
  |  [Rate Limiting]                       [Absolute Claims]    |
  |    |                                              ^          |
  |    v                                              |          |
  |  [============= Claude AI Processing =============]         |
  |                                                              |
  |  Every action logged to immutable audit trail (JSONL)        |
  +------------------------------------------------------------+
```

- Zero PII exposure to external APIs
- Every query, tool call, and response fully auditable
- Documents validated against FDA/ICH standards before delivery
- Rate limiting prevents abuse and controls costs

---

<!-- SLIDE 7: COMPETITIVE ADVANTAGE -->

## Why PharmaAgent Pro?

### vs. General-Purpose AI Chatbots (ChatGPT, Generic Claude)

| Capability | Generic AI | PharmaAgent Pro |
|-----------|-----------|----------------|
| Pharma-specific tools | No | 6 specialized tools with pharma datasets |
| Regulatory compliance | No | Built-in ICH/FDA validation |
| PII protection | Basic | Multi-layer detection + redaction |
| Audit trail | No | Immutable JSONL logging of every action |
| Extended thinking | No | Transparent reasoning for complex analyses |
| Multi-agent routing | No | Specialized agents per domain |
| Cost tracking | No | Per-query token + cost estimation |

### vs. Traditional Pharma Software

| Capability | Legacy Tools | PharmaAgent Pro |
|-----------|-------------|----------------|
| Natural language queries | No | Full conversational interface |
| Cross-domain analysis | Siloed | Unified platform, 4 domains |
| Setup time | Months | Minutes (single API key) |
| Document generation | Templates only | AI-generated with context awareness |
| Learning curve | High | Ask questions in plain English |

---

<!-- SLIDE 8: TECHNOLOGY STACK -->

## Technology Stack

```
  +--------------------------------------+
  |         User Interfaces               |
  |  Terminal CLI | Web UI | REST API     |
  +--------------------------------------+
  |         Agent Framework               |
  |  Claude Managed Agent SDK (Python)    |
  |  Multi-model: Opus | Sonnet | Haiku   |
  +--------------------------------------+
  |         Intelligence Layer            |
  |  Extended Thinking | Prompt Caching   |
  |  Tool-Based Retrieval | Memory Store  |
  +--------------------------------------+
  |         Safety Layer                  |
  |  Input Validation | Output Filtering  |
  |  Compliance Checking | Rate Limiting  |
  +--------------------------------------+
  |         Infrastructure                |
  |  Audit Logging | Usage Tracking       |
  |  Structured Logging | Config Mgmt     |
  +--------------------------------------+
  |         Deployment                    |
  |  platform.claude.com (Managed Agent)  |
  |  Docker | FastAPI | SSE Streaming     |
  +--------------------------------------+
```

---

<!-- SLIDE 9: CASE STUDY -->

## Example Workflow: Safety Signal to Regulatory Report

### Scenario: Oncolytin-B ILD Signal Detection

```
Step 1: Signal Detection (30 seconds)
+---------------------------------------------------------------+
| User: "Run safety signal analysis on Oncolytin-B"              |
|                                                                 |
| PharmaAgent Pro:                                                |
|   -> Calls safety_signal_analysis tool                          |
|   -> Analyzes 3 adverse events, identifies 2 SAEs              |
|   -> Flags ILD in Respiratory SOC (disproportionate signal)     |
|   -> Status: ALERT -- Immediate DSMB review recommended         |
+---------------------------------------------------------------+
                            |
                            v
Step 2: Deep Dive (45 seconds)
+---------------------------------------------------------------+
| User: "Show me all SAEs for this compound with narratives"      |
|                                                                 |
| PharmaAgent Pro:                                                |
|   -> Calls adverse_event_search (serious_only=true)             |
|   -> Returns 2 SAE records with full narratives                 |
|   -> ILD: Grade 3, drug discontinued, possibly related          |
|   -> QTc: Grade 2, dose reduced, probably related               |
+---------------------------------------------------------------+
                            |
                            v
Step 3: Regulatory Report (90 seconds)
+---------------------------------------------------------------+
| User: "Generate a CIOMS safety report for the ILD event"        |
|                                                                 |
| PharmaAgent Pro:                                                |
|   -> Calls generate_document (type=safety_report_cioms)         |
|   -> Produces ICH E2A-compliant CIOMS I form                    |
|   -> Includes: patient info, AE details, suspect drug,          |
|     narrative, causality, document control signatures            |
|   -> Validated against compliance checklist                     |
+---------------------------------------------------------------+

Total time: ~3 minutes
Traditional process: 3-5 days
```

---

<!-- SLIDE 10: FEATURE ROADMAP -->

## Feature Roadmap

```
  NOW            Q3 2026          Q4 2026          2027
   |               |                |                |
   v               v                v                v

  [CURRENT]     [PHASE 2]       [PHASE 3]        [PHASE 4]
   MVP            Multi-Agent     Enterprise        Advanced AI
                  Orchestration   Features          Intelligence
   |               |                |                |
   |  6 pharma     |  Parallel      |  RBAC &        |  Literature
   |  tools        |  agent exec    |  multi-tenant   |  RAG
   |               |                |                |
   |  4 domain     |  Agent-to-     |  FDA FAERS     |  Predictive
   |  agents       |  agent comms   |  API live       |  safety
   |               |                |  connector      |  modeling
   |  Guardrails   |  Supervisor    |                |
   |  & compliance |  agent for     |  Document      |  Automated
   |               |  consistency   |  versioning &   |  IND/NDA
   |  Audit trail  |                |  approval       |  assembly
   |  & tracking   |  Dynamic tool  |  workflows      |
   |               |  discovery     |                |  Multi-modal
   |  Managed      |                |  Scheduled     |  analysis
   |  Agent deploy |  Conflict      |  monitoring &   |  (images,
   |               |  resolution    |  alerting       |  charts)
   |               |                |                |
   +---------------+----------------+----------------+
```

### Key Milestones

| Phase | Timeline | Highlights |
|-------|----------|-----------|
| **Phase 1 (Current)** | Live | 6 tools, 4 agents, managed agent deployment, web + CLI chatbot |
| **Phase 2** | Q3 2026 | Parallel agent execution, agent-to-agent communication, supervisor agent |
| **Phase 3** | Q4 2026 | Enterprise RBAC, live data connectors (FAERS, ClinicalTrials.gov), document workflows |
| **Phase 4** | 2027 | Literature RAG, predictive safety, automated submission assembly, multi-modal |

### Upcoming Highlights

**Multi-Agent Orchestration** (Phase 2):
- Run Drug Discovery + Safety agents in parallel for cross-domain queries
- Supervisor agent reviews outputs for consistency
- Agents can request data from each other dynamically

**Enterprise Features** (Phase 3):
- Role-based access: researchers see different tools than regulatory staff
- Live FDA FAERS API integration for real-world safety data
- Automated daily safety scans with Slack/email alerting

**Advanced Intelligence** (Phase 4):
- RAG over biomedical literature (PubMed, FDA labels)
- Predict safety signals before they reach statistical significance
- Assemble complete IND/NDA submission packages automatically

---

<!-- SLIDE 11: GETTING STARTED -->

## Getting Started

### 3-Minute Setup

```
1. Clone the repository
   git clone <repo-url> && cd ClaudeManagedAgentApp

2. Install dependencies
   pip install -e ".[dev]"

3. Set your API key
   echo "ANTHROPIC_API_KEY=sk-ant-..." > .env

4. Launch the chatbot
   python -m src.main

5. Or deploy to Claude Platform
   python deploy/deploy_managed_agent.py
   python deploy/chatbot_server.py
   Open http://localhost:3000
```

### Try These Queries

| Query | What Happens |
|-------|-------------|
| "Analyze Nexavirin drug-likeness" | Drug Discovery agent profiles compound, assesses Lipinski |
| "Show ONCOLYZE-3 trial status" | Clinical Trials agent pulls enrollment, endpoints, results |
| "Run safety signal analysis on Oncolytin-B" | Safety agent detects ILD signal, recommends DSMB review |
| "Generate CIOMS report for Immunex-340 hepatitis SAE" | Regulatory agent produces ICH E2A-compliant document |
| "Check interactions between Nexavirin and Inflammablock" | Drug Discovery agent analyzes CYP enzyme overlap |

---

<!-- SLIDE 12: CONTACT -->

## Summary

**PharmaAgent Pro** transforms pharmaceutical R&D by putting an AI-powered research team at every scientist's fingertips.

```
  +------------------+     +------------------+     +------------------+
  |  FASTER           |     |  SAFER            |     |  SMARTER         |
  |                    |     |                    |     |                  |
  |  Signal detection  |     |  Zero PII exposure |     |  AI reasons      |
  |  in seconds,       |     |  to external APIs  |     |  through complex |
  |  not weeks         |     |                    |     |  drug interactions|
  |                    |     |  Full audit trail   |     |                  |
  |  Documents in      |     |  for compliance     |     |  Multi-agent     |
  |  minutes, not days |     |                    |     |  specialization  |
  +------------------+     +------------------+     +------------------+
```

**Built on Claude. Engineered for Pharma. Ready for Production.**

---

*PharmaAgent Pro is built on Anthropic's Claude Managed Agent Platform.*
*For technical details, see the Technical Guide (docs/TECHNICAL_GUIDE.md).*
